Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» US FDA approves Raptor Pharma's Procysbi for treatment of nephropathic cystinosis
US FDA approves Raptor Pharma's Procysbi for treatment of nephropathic cystinosis
US FDA approves Raptor Pharma's Procysbi for treatment of nephropathic cystinosis
Submitted by
admin
on May 5, 2013 - 11:07am
Source:
Pharmabiz
News Tags:
Raptor Pharmaceuticals
procysbi
nephropathic cystinosis
Headline:
US FDA approves Raptor Pharma's Procysbi for treatment of nephropathic cystinosis
Do Not Allow Advertisers to Use My Personal information
